Information:
Fel:
ID
34263
Beskrivning
Promoting Adherence to Improve Effectiveness of Cardiovascular Disease Therapies; ODM derived from: https://clinicaltrials.gov/show/NCT01251757
Länk
https://clinicaltrials.gov/show/NCT01251757
Nyckelord
Versioner (1)
- 2019-01-16 2019-01-16 -
Rättsinnehavare
see on clinicaltrials.gov
Uppladdad den
16 januari 2019
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Diabetes Mellitus NCT01251757
Eligibility Diabetes Mellitus NCT01251757
- StudyEvent: Eligibility
Similar models
Eligibility Diabetes Mellitus NCT01251757
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
ID.1
Item
aged 40-80 years as of time of randomization.
boolean
ID.2
Item
two or more medication dispensings for any prescription medication from a kp outpatient pharmacy during the baseline year.
boolean
ID.3
Item
flagged in kp's databases as having either diabetes or atherosclerotic cardiovascular disease(defined as coronary artery disease, peripheral vascular disease, or a history of atherosclerotic stroke)
boolean
ID.4
Item
continuous membership in kp for the 12 months prior to randomization.
boolean
ID.5
Item
willing to participate in the study.
boolean
ID.6
Item
evidence in the emr of allergy or intolerance to statins, ace inhibitors/arbs,or aspirin
boolean
ID.7
Item
use of warfarin or other antiplatelet agents for which aspirin use is contraindicated
boolean
ID.8
Item
end-stage renal disease or other conditions for which ace inhibitor or arb use is contraindicated
boolean
ID.9
Item
use of medications for which use of statins is contraindicated
boolean